Labcorp (NYSE:LH) (NYSE:LH), formally Laboratory Corporation of America Holdings, is a global life sciences and laboratory services company headquartered in Burlington, North Carolina. The company provides diagnostic testing, drug development services and technology-enabled laboratory solutions to healthcare providers, pharmaceutical and biotechnology companies, government agencies and consumers.
Its diagnostics business offers routine and specialty laboratory testing, including testing related to oncology, women’s health, infectious diseases, genetics and genomics. Labcorp also provides employer drug testing, clinical trials laboratory services and other testing solutions designed to support patient care, research and public health.
Through its drug development operations, Labcorp supports pharmaceutical and biotechnology companies with clinical trial management, laboratory testing, biomarker services, regulatory support and related research capabilities. The company serves customers in the United States and internationally, with its clinical development and laboratory operations supporting studies and healthcare activities across multiple global markets.
Labcorp traces its origins to National Health Laboratories and was created in its current form through the 1995 merger of National Health Laboratories and Roche Biomedical Laboratories. Adam Schechter has served as the company’s president and chief executive officer since 2021.
